Laurence J. Egan

9.5k total citations · 4 hit papers
83 papers, 7.2k citations indexed

About

Laurence J. Egan is a scholar working on Genetics, Immunology and Surgery. According to data from OpenAlex, Laurence J. Egan has authored 83 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Genetics, 25 papers in Immunology and 20 papers in Surgery. Recurrent topics in Laurence J. Egan's work include Inflammatory Bowel Disease (37 papers), Microscopic Colitis (15 papers) and NF-κB Signaling Pathways (12 papers). Laurence J. Egan is often cited by papers focused on Inflammatory Bowel Disease (37 papers), Microscopic Colitis (15 papers) and NF-κB Signaling Pathways (12 papers). Laurence J. Egan collaborates with scholars based in Ireland, United States and United Kingdom. Laurence J. Egan's co-authors include Martin F. Kagnoff, William J. Sandborn, Florian R. Greten, Michael Karin, Lars Eckmann, Zhiwei Li, Jin Mo Park, Tim F. Greten, Edward V. Loftus and William S. Harmsen and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Laurence J. Egan

79 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer

2004 2.0k citations Florian R. Greten, Lars Eckmann et al. profile →
Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

2008 770 citations Murat Törüner, Edward V. Loftus et al. profile →
The safety profile of infliximab in patients with Crohn’s disease: The Mayo Clinic experience in 500 patients

2003 671 citations Edward V. Loftus, William J. Tremaine et al. profile →
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies

2015 284 citations Laurence J. Egan et al. profile →

Peers

Countries citing papers authored by Laurence J. Egan

Since Specialization

Citations

This map shows the geographic impact of Laurence J. Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence J. Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence J. Egan more than expected).

Fields of papers citing papers by Laurence J. Egan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence J. Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence J. Egan. The network helps show where Laurence J. Egan may publish in the future.

Co-authorship network of co-authors of Laurence J. Egan

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence J. Egan. A scholar is included among the top collaborators of Laurence J. Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence J. Egan. Laurence J. Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A single‐centre analysis of a biosimilar switching programme for adalimumab in inflammatory bowel disease 2025 ·British Journal of Clinical Pharmacology ·(unknown), (unknown), (unknown), John Ferguson, (unknown), Brian E. McGuire, Patrick Gillespie, Laurence J. Egan	1
2	Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signaling 2024 ·iScience ·Niamh Leonard, (unknown), (unknown), (unknown), Grace O’Malley, Kerry Thompson, (unknown), (unknown), Norashikin Zakaria, Laurence J. Egan, Thomas Ritter, Daniela Loessner, Keara L. Redmond, Mary C. Sheehan, Aoife Canney, Aisling Hogan, Seán O. Hynes, Oliver Treacy, Philip D. Dunne, Aideen E. Ryan	8
3	Subtotal colectomy in ulcerative colitis—long term considerations for the rectal stump 2021 ·World Journal of Gastrointestinal Surgery ·(unknown), Laurence J. Egan, Myles Joyce	8
4	Stromal Cell PD-L1 Inhibits CD8+ T-cell Antitumor Immune Responses and Promotes Colon Cancer 2018 ·Cancer Immunology Research ·Grace O’Malley, Oliver Treacy, Kevin Lynch, (unknown), Niamh Leonard, Paul Lohan, Philip D. Dunne, Thomas Ritter, Laurence J. Egan, Aideen E. Ryan	68
5	Infliximab Selectively Modulates the Circulating Blood Monocyte Repertoire in Crohnʼs Disease 2016 ·Inflammatory Bowel Diseases ·(unknown), Michael Conall Dennedy, (unknown), Andreia Ribeiro, Rhodri Ceredig, Matthew D. Griffin, Laurence J. Egan	10
6	New Insights into the Mechanisms of Action of Anti–Tumor Necrosis Factor-α Monoclonal Antibodies in Inflammatory Bowel Disease 2015 ·Inflammatory Bowel Diseases ·(unknown), Laurence J. Egan	44
7	How to Manage the Risk of Colorectal Cancer in Ulcerative Colitis 2011 ·Current Drug Targets ·Raja Affendi Raja Ali, Laurence J. Egan	5
8	Is There a Role for Nuclear Factor κB in Tumor Necrosis Factor‐Related Apoptosis‐Inducing Ligand Resistance? 2009 ·Annals of the New York Academy of Sciences ·(unknown), Éva Szegezdi, Afshin Samali, Laurence J. Egan	18
9	Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial 2008 ·Gastrointestinal Endoscopy ·Craig A. Solem, Edward V. Loftus, Joel G. Fletcher, Todd H. Baron, Christopher J. Gostout, Bret T. Petersen, William J. Tremaine, Laurence J. Egan, William A. Faubion, Kenneth W. Schroeder, Darrell S. Pardi, Karen A. Hanson, (unknown), John M. Barlow, Jeff L. Fidler, James E. Huprich, C. Daniel Johnson, William S. Harmsen, Alan R. Zinsmeister, William J. Sandborn	247
10	Pharmacogenomics in Inflammatory Bowel Disease 2006 ·Clinical Gastroenterology and Hepatology ·Laurence J. Egan, Luc J. J. Derijks, Daniël W. Hommes	20
11	NF‐κB Signaling 2006 ·Annals of the New York Academy of Sciences ·Laurence J. Egan, Murat Törüner	43
12	Expression of Epstein–Barr virus‐induced gene 3 and other interleukin‐12‐related molecules by human intestinal epithelium 2004 ·Immunology ·Christian Maaser, Laurence J. Egan, Mark Birkenbach, Lars Eckmann, Martin F. Kagnoff	29
13	The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion 2003 ·Nature Medicine ·Lee-Wei Chen, Laurence J. Egan, Zhi-Wei Li, Florian R. Greten, Martin F. Kagnoff, Michael Karin	420
14	Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-κB and MAP kinase pathways and the upregulated expression of interleukin 8 2002 ·Cellular Microbiology ·M. Cecilia Berin, Arlette Darfeuille–Michaud, Laurence J. Egan, Yukiko Miyamoto, Martin F. Kagnoff	127
15	Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: A case study of five patients with treatment-resistant inflammatory bowel disease 2000 ·Inflammatory Bowel Diseases ·Laurence J. Egan, William J. Tremaine, Dennis C. Mays, James J. Lipsky, William J. Sandborn	13
16	Endoscopic Removal of an Embedded Biliary Wallstent by Piecemeal Extraction 2000 ·Endoscopy ·Laurence J. Egan, Todd H. Baron	15
17	New Perspectives in Gastric Acid Suppression: Genetic Polymorphisms Predict the Efficacy of Proton Pump Inhibitors 2000 ·Digestive Diseases ·Laurence J. Egan, Joseph A. Murray	10
18	Plasma and Rectal Adenosine in Inflammatory Bowel Disease: Effect of Methotrexate 1999 ·Inflammatory Bowel Diseases ·Laurence J. Egan, William J. Sandborn, Dennis C. Mays, William J. Tremaine, James J. Lipsky	16
19	Clinical Outcome Following Treatment of Refractory Inflammatory and Fistulizing Crohn's Disease With Intravenous Cyclosporine 1998 ·The American Journal of Gastroenterology ·Laurence J. Egan, William J. Sandborn, William J. Tremaine	143
20	Herpetic Whitlow of the Toe: An Unusual Manifestation of Infection with Herpes Simplex Virus Type 2 1998 ·Clinical Infectious Diseases ·Laurence J. Egan, (unknown), David C. Agerter, Randall S. Edson	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact